TearClear Moving Toward Clinical Trials and Strengthening Leadership Team
UF startup and UF Innovate | Sid Martin Biotech resident client TearClear, an emerging ophthalmic pharmaceutical company, continues to make progress on the development of its first-in-class platform of preservative-free topical medications.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed